Proprietary low-energy pacing technology offers potential for pain-free cardiac defibrillation with significantly fewer complications and side effects FRIEDBERG, Germany and BAYERN, Germany, May 04, 2020 (GLOBE NEWSWIRE) — Advanced BioInformatics GmbH, a medical technology company developing solutions that improve long-term outcomes for people with cardiac arrhythmias, today announced that the […]
Other News
Endonovo Therapeutics Announces Positive 2019 Fiscal Results
Los Angeles, CA, May 04, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”) today reported financial results for fiscal year ended December 31, 2019. Key Financial Highlights: Revenues for the year ended December 31, 2019 increased by 273% to $310,164, as compared to $83,263 in […]
Teleflex Announces Quarterly Dividend
WAYNE, Pa., May 04, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2020 to shareholders of record at the close of business on […]
Itamar Medical Receives CE Mark Approval for its WatchPAT™ ONE, the First Fully Disposable Home Sleep Apnea Test
Complete, home-based solution for diagnosing respiratory sleep disorders approved for commercialization in Europe and other CE Mark geographies CAESAREA, Israel, May 04, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical solutions to aid in […]
Inositec Granted US Composition of Matter Patent for Cardiovascular Calcification Inhibitor INS-3001
ZURICH–(BUSINESS WIRE)–Inositec, a pioneer in the development of life-saving small molecule drugs based on the natural compound inositol hexaphosphate (IP6), announced today that the U.S. Patent and Trademark Office (USPTO) has issued a patent covering its platform of inositol phosphate analogs and specifically INS-3001, an inhibitor of pathological soft tissue […]
Acceleron Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Sotatercept in Pulmonary Arterial Hypertension
First therapeutic to receive PRIME designation in pulmonary arterial hypertension since the EMA established the program in 2016 PRIME designation comes just three weeks after US FDA granted sotatercept Breakthrough Therapy designation CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq: XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of […]
Sequana Medical Announces the Appointment of Dr. Oliver Gödje as Chief Medical Officer
GHENT, Belgium, May 04, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer, with immediate effect. Dr Gödje replaces Gijs Klarenbeek, MD, […]
CryoLife Reports First Quarter 2020 Financial Results
ATLANTA, April 30, 2020 /PRNewswire/ — First Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 2020 versus preliminary first quarter 2020 revenues of $65.5 million Total revenues decreased 2% and decreased 1% on a constant currency basis versus first quarter 2019 Excluding TMR, total revenues increased 1% and […]
The American Society For Preventive Cardiology (ASPC) Releases Official Scientific Statement On Continuity Of Care And Outpatient Management For Patients With And At High Risk For Cardiovascular Disease During The COVID-19 Pandemic
JACKSONVILLE, Fla., May 1, 2020 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) has released an official scientific statement titled: Continuity of Care and Outpatient Management for Patients With and At High Risk for Cardiovascular Disease During the COVID-19 Pandemic: A Scientific Statement. This official scientific statement, created by a team of […]
BioSig Resumes Clinical Activities with PURE EP System
Westport, CT, May 01, 2020 (GLOBE NEWSWIRE) — Clinical support staff to return to perform elective procedures at Texas Cardiac Arrhythmia Institute as of May 4, 2020 Company reconfirms its commitment to commercial installations this year BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing […]



